We observed the following aspects: CDKN2A deletions associated with midline shift presented an HR of 1.22 (p = 0.015), and CDKN2A deletions associated with the presence of residual tumor had an HR of 9.41 (p = 0.016). This evidence concerns the gene CDKN2A and neoplasm.